marginal significanceP = 0.045
A higher fraction of patients with a cT3–4 were ctDNA‐positive (74%) compared with cT1–2 (48%), with marginal significance ( P = 0.045).
A higher fraction of patients with a cT3–4 were ctDNA‐positive (74%) compared with cT1–2 (48%), with marginal significance ( P = 0.045).
While we observed an increasing trend in ctDNA positivity with advancing clinical stages, the differences were not statistically significant, likely due to the limited number of patients in each category.